OPKO Health Inc. (OPK)
NASDAQ: OPK
· Real-Time Price · USD
1.37
0.00 (0.00%)
At close: Jun 06, 2025, 10:38 AM
OPKO Health Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Product Revenue | 155.11M | 167.56M | 142.84M | 1.61B | 1.26B | 716.43M | 107.11M |
| Product Revenue Growth | -7.43% | +17.30% | -91.11% | +27.32% | +76.18% | +568.86% | n/a |
| Service Revenue | 480.67M | 515.27M | 755.63M | 141.77M | 119.95M | n/a | 813.25M |
| Service Revenue Growth | -6.72% | -31.81% | +433.00% | +18.19% | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chile Revenue | 65.05M | 68.49M | 62.04M | 63.8M | 44.15M | 33.64M | 41.22M | 44.29M | 35.36M | 29.89M | 29.15M | 31.65M | 26.51M |
| Chile Revenue Growth | -5.03% | +10.39% | -2.75% | +44.49% | +31.24% | -18.38% | -6.93% | +25.23% | +18.33% | +2.51% | -7.89% | +19.37% | n/a |
| Ireland Revenue | 48.4M | 141.47M | 117.21M | 32.81M | 43.92M | 81.17M | 78.1M | 77.28M | 137.78M | 78.99M | 20.64M | 4.46M | 7.66M |
| Ireland Revenue Growth | -65.79% | +20.69% | +257.26% | -25.30% | -45.89% | +3.93% | +1.06% | -43.91% | +74.44% | +282.74% | +362.84% | -41.75% | n/a |
| Israel Revenue | 1.77M | 9.74M | 3.85M | 3.56M | 4.25M | 8.77M | 9.48M | 13.95M | 15.32M | 18.11M | 5.81M | n/a | 5M |
| Israel Revenue Growth | -81.80% | +153.26% | +7.91% | -16.18% | -51.52% | -7.49% | -32.06% | -8.92% | -15.41% | +211.81% | n/a | n/a | n/a |
| Mexico Revenue | 23.87M | 20.22M | 14.55M | 11.01M | 7.87M | 8.03M | 5.6M | 4.61M | 2.99M | 3.67M | 21.32M | n/a | 6.12M |
| Mexico Revenue Growth | +18.06% | +38.98% | +32.18% | +39.92% | -2.08% | +43.48% | +21.56% | +54.12% | -18.61% | -82.78% | n/a | n/a | n/a |
| Other Countries Revenue | 3.12M | 2.25M | 863K | 507K | 526K | 476K | 167K | 120K | 6K | n/a | 14.14M | n/a | 1.75M |
| Other Countries Revenue Growth | +39.05% | +160.25% | +70.22% | -3.61% | +10.50% | +185.03% | +39.17% | +1900.00% | n/a | -100.00% | n/a | n/a | n/a |
| Spain Revenue | 24.63M | 23.52M | 22.48M | 22.68M | 16.93M | 18.75M | 18.2M | 18.29M | 15.81M | 16.62M | n/a | n/a | n/a |
| Spain Revenue Growth | +4.75% | +4.63% | -0.90% | +33.96% | -9.68% | +3.03% | -0.49% | +15.64% | -4.87% | n/a | n/a | n/a | n/a |
| United States Revenue | 546.3M | 597.82M | 783.21M | 1.64B | 1.32B | 751.1M | 837.51M | 908.97M | 1.01B | 344.46M | n/a | n/a | n/a |
| United States Revenue Growth | -8.62% | -23.67% | -52.25% | +24.48% | +75.45% | -10.32% | -7.86% | -10.39% | +194.48% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 59.09M | 67.03M | 98.2M | 68.82M | 70.17M | 72.9M | 72.3M | 79.79M | 75.7M | 74M | 79.67M | 101.46M | 117.54M | 138.2M | 105.12M | 113.24M | 112.29M | 101.8M | 99.9M | 77.72M | 76.13M | 79.1M | 80.54M | 88.47M | 95.2M | 95.1M | 84.07M | 87.65M | 91.5M | 124.6M | 131.34M | 128.34M | 136.69M | 120.5M | 124.9M | 117.51M | 128M | 102.95M | 55.25M | 20.94M | 17.45M |
| Selling, General, and Administrative Revenue Growth | -11.85% | -31.74% | +42.69% | -1.92% | -3.75% | +0.83% | -9.39% | +5.41% | +2.30% | -7.12% | -21.48% | -13.67% | -14.95% | +31.47% | -7.17% | +0.85% | +10.30% | +1.90% | +28.53% | +2.09% | -3.75% | -1.79% | -8.97% | -7.06% | +0.11% | +13.12% | -4.09% | -4.20% | -26.57% | -5.13% | +2.34% | -6.11% | +13.43% | -3.52% | +6.29% | -8.20% | +24.34% | +86.34% | +163.87% | +20.01% | n/a |
| Research and Development Revenue | 30.84M | 30.43M | 28.77M | 24.08M | 21.94M | 19.4M | 19.4M | 18.16M | 32.6M | 19.5M | 18.79M | 17.25M | 18.31M | 21M | 18.31M | 18.22M | 19.32M | 17.5M | 18.49M | 17.61M | 21.76M | 23M | 30.02M | 28.29M | 36.5M | 33.3M | 30.16M | 29.21M | 32.9M | 34.2M | 32.33M | 32.59M | 26.02M | 27.6M | 24.4M | 31.35M | 27.82M | 25.48M | 18.94M | 29.57M | 25.5M |
| Research and Development Revenue Growth | +1.37% | +5.75% | +19.47% | +9.78% | +13.08% | 0.00% | +6.83% | -44.30% | +67.18% | +3.77% | +8.91% | -5.78% | -12.80% | +14.72% | +0.46% | -5.66% | +10.37% | -5.37% | +5.03% | -19.08% | -5.39% | -23.38% | +6.12% | -22.50% | +9.61% | +10.41% | +3.25% | -11.21% | -3.80% | +5.79% | -0.81% | +25.25% | -5.72% | +13.11% | -22.16% | +12.67% | +9.20% | +34.54% | -35.96% | +15.95% | n/a |